We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Diabetes in pregnancy among First Nations women in Alberta, Canada: a retrospective analysis
BMC Pregnancy and Childbirthvolume 14, Article number: 136 (2014)
In addition to increasing the risk of adverse birth outcomes, diabetes in pregnancy is thought to be an important driver of the epidemic of type 2 diabetes affecting Canada’s First Nations population. The relative contributions of gestational diabetes mellitus (GDM) and pre-existing diabetes are not well understood. We generated a comprehensive epidemiological profile of diabetes in pregnancy over a 10-year period among the First Nations population of Alberta, Canada.
De-identified administrative data for 427,058 delivery records were obtained for the years 2000–2009. Pregnancy risk factors and delivery outcomes were described and compared by ethnicity (First Nations vs. non-First Nations) and diabetes status. Age-adjusted prevalence values for GDM and pre-existing diabetes were calculated and were compared by ethnicity. Longitudinal changes over time were also examined. Predictors were explored using logistic regression analysis.
First Nations women had more antenatal risk factors and adverse infant outcomes that were compounded by diabetes. First Nations descent was an independent predictor of diabetes in pregnancy (p < 0.001). GDM prevalence was significantly higher among First Nations (6.1%) compared to non-First Nations women (3.8%; p < 0.001), but prevalence values increased significantly over time only in non-First Nations women (4.5 average annual percent change; p < 0.05). The prevalence of pre-existing diabetes was stable over time in both groups, but First Nations women experienced a 2.5-fold higher overall prevalence compared with non-First Nations women (1.5% vs. 0.6%, respectively; p < 0.001).
Although First Nations women experience a higher overall prevalence of diabetes in pregnancy, the lack of increase in the prevalence over time is encouraging. However, because high-risk pregnancies and poor outcomes are more common among First Nations women, particularly those with diabetes, strategies to improve perinatal care must be implemented.
Diabetes in pregnancy [i.e., pre-existing diabetes and gestational diabetes mellitus (GDM)] is a major risk factor for perinatal complications, future obesity, and type 2 diabetes in mothers and their offspring [1–3]. This relationship is particularly strong if blood sugar remains unmanaged. Consequently, diabetes in pregnancy is considered to be a key predictor of, and contributor to, the current increases in type 2 diabetes worldwide, particularly in Indigenous populations . Prevalence and incidence of type 2 diabetes has increased rapidly in Canada’s most populous Indigenous group (the First Nations) over the past half century and are currently 2–5 times greater than in the general Canadian population [5–7]. First Nations women generally suffer from a higher type 2 diabetes prevalence compared with their male counterparts [4, 6–8].
Pregnancy may be a crucial point for interventions and appropriate healthcare aimed at reducing the prevalence of type 2 diabetes in First Nations peoples [2, 9–11]. However, insufficient awareness and gaps in a detailed understanding of diabetes in pregnancy may be contributing to the lack of progress in reversing the epidemic. Knowledge about the extent of the problem of diabetes in pregnancy among First Nations women (namely prevalence, longitudinal trends in prevalence, and predictors of diabetes) is based primarily on cross-sectional studies focusing on crude GDM prevalence. Longitudinal data and data on pre-existing diabetes in pregnancy are limited. Other important maternal factors and pregnancy outcomes related to GDM and pre-existing diabetes in pregnancy have yet to be explored in this population. These factors and outcomes include the presence of pregestational hypertension, proteinuria or anemia, and smoking, alcohol consumption, illicit drug use, prior obstetrical history, breastfeeding, neonatal intensive care unit (NICU) admission, and preterm delivery. For these reasons, the current study was designed to use provincial administrative data to generate an epidemiological profile of First Nations diabetes in pregnancy in the province of Alberta.
The Human Research Ethics Board of the University of Alberta approved the research protocol. Each province in Canada has different and separate procedures for collecting perinatal data. The Alberta Perinatal Health Program (APHP) comprehensively collects perinatal data from the provincial delivery record for all hospital births and registered midwife-attended home births. Delivery record information is recorded by a healthcare provider (usually a nurse) when a woman presents for delivery. This information is obtained from prenatal records and/or from the patient. Surveillance reports derived from Alberta delivery records and APHP data are also published . Pertinent de-identified data from all delivery records were requested for the years 2000–2009 (complete data for 2010 and later were not available at the time of the request). Data from multiple pregnancies were included in the request. Data were complete or nearly complete (available for 97%–100% of pregnancies) for the majority of the variables.
During the time period of the obtained data, GDM diagnosis followed Canadian Diabetes Association guidelines . Diagnosis included screening at 24–28 weeks with an initial 50-g oral glucose challenge and a subsequent blood glucose measurement at 1 hour post-consumption. A result of < 7.8 mmol L-1 was considered to be a normal result. A result of ≥ 10.3 mmol L-1 was considered to indicate the presence of GDM. A subsequent 75-g oral glucose tolerance test for the potential diagnosis of GDM was indicated to follow up a result between 7.8–10.2 mmol L-1. Two separate values of either fasting glucose ≥ 5.3 mmol L-1, a 1-hour post-consumption glucose ≥ 10.6 mmol L-1, or a 2-hour post-consumption glucose ≥ 8.9 mmol L-1 confirmed a diagnosis of GDM . The presence of specific risk factors (e.g., previous diagnosis of GDM or delivery of a macrosomic infant, member of a high risk population, age > 35, obesity, polycystic ovarian syndrome, acanthosis nigricans, or corticosteroid use) was a clinical indication for the performance of glucose testing in the first trimester. A positive result indicated the presence of “overt diabetes” (usually previously unrecognized or undiagnosed type 2 diabetes) [13, 14], which would have been recorded as pre-existing diabetes. A diagnosis of pre-existing diabetes was otherwise made from an assessment of patient history, clinical chart records, and medication records (insulin or oral antihyperglycemic agents). We were unable to discern which pre-existing diabetes cases were type 1 diabetes and which were type 2 diabetes. Descriptions of the other variables included in the analyses are presented in Additional file 1. Because data on breastfeeding were available for just 33% (i.e., not for the entire province) of the pregnant mothers, these data were used only for descriptive purposes and were not included in the regression models. The delivery records included calculation of a composite antepartum risk score, which was a weighted summary measure of pregnancy risk factors (45-item score of pre-pregnancy, previous obstetrical history, problems in current pregnancy and other risk factors). Women that received a score ≥ 7 were considered to have high risk pregnancies. The variables used and the scoring details are available from the APHP . They were used in a recent retrospective study that assessed the association between the Alberta antepartum risk score and perinatal morbidity outcomes .
The three types of Indigenous peoples recognized by Canada are the First Nations, the Métis (mixed heritage), and the Inuit peoples. Each group possesses distinct cultural identities and has distinct governance and healthcare systems. First Nations and Inuit individuals whose Nations have engaged in Treaties are accorded “registered Indian” or Treaty status, which includes a “status card” that confers a number of Treaty rights, including access to healthcare services. The Alberta Health Care Insurance Plan Central Stakeholder Registry file [Ministry of Alberta Health (AH), Surveillance Division] includes an identifier for individuals with registered Indian status. Data obtained from the APHP were sent to AH for matching via the Personal Health Number. First Nations individuals were defined as any Alberta resident registered under the Indian Act of Canada and entitled to Treaty status with the Canadian Government. A woman with a First Nations identifier (i.e., First Nations or Inuit) was classified as “First Nations” if her infant was delivered in Alberta. Other persons recognized by Canada (e.g., the Métis), or self-identified as Indigenous but non-registered (such as First Nations individuals without Treaty status), were included in the general population comparison group because they could not be identified in the administrative database. In Alberta, there are approximately 116,670 First Nations people (19,945 of these are non-registered) and 96,865 Métis people, representing approximately 3.3% and 2.7% of the total population, respectively . Very few Inuit people (approximately 1,600) reside in Alberta. The complete set of de-identified data was returned by AH in STATA statistical software (StataCorp LP, College Station, TX, USA) format.
All analyses were performed using STATA (version 11) and Joinpoint (version 3.5.1, Rockville, Maryland, USA) statistical software. P-values < 0.05 were considered to be statistically significant. The prevalence and mean values for maternal characteristics, pre-existing maternal risk factors, problems with the current pregnancy, maternal outcomes, and newborn outcomes were calculated. Prevalence calculations were completed separately for the following groups: all First Nations pregnancies without diabetes, all non-First Nations pregnancies without diabetes, all First Nations pregnancies with diabetes, all non-First Nations pregnancies with diabetes, all First Nations pregnancies with pre-existing diabetes, and all First Nations pregnancies with GDM. For the prevalence calculations, the denominator was the total number of pregnancies where data on that variable were available for the specific group of interest. The numerator was the total number of pregnancies for which the criteria for the variable of interest was met, for the specific group of interest. Comparisons were by ethnicity (First Nations vs. non-First Nations) among individuals without diabetes and individuals with diabetes. Differences between First Nations women with and without diabetes were also estimated. Finally, comparisons by diabetes type (GDM vs. pre-existing diabetes; type 1 and type 2 diabetes combined) were made among First Nations women with diabetes alone. Chi-square analysis (for categorical variables) and t-tests (for continuous variables) were used for the comparisons.
Our primary focus was to examine trends in, and risk factors for, diabetes in pregnancy. Annual age-adjusted prevalence of GDM and pre-existing diabetes for the entire province by ethnicity were calculated using the direct method. Maternal age distribution data for the total number of pregnancies in 2005 were obtained from Canadian Vital Statistics  and were used as the reference population for age-adjustment. Crude prevalence values were also calculated for comparison with results from previous studies. For the longitudinal analyses (i.e., examination of changes in trends over time), the average annual percent change (AAPC) in GDM and pre-existing diabetes prevalence values over time were computed and were compared between ethnic groups. The AAPC provided a summary measure of the trend over a pre-specified fixed interval (2000–2009). Tests of parallelism were then performed to determine whether trends over time differed by ethnic group.
Multivariable logistic regression modeling (purposeful) was used to evaluate the relationships between GDM and potential explanatory variables (i.e., pre-existing maternal risk factors, past obstetrical variables, problems with current pregnancy). The logistic regression analysis was repeated using pre-existing diabetes as the dependent variable. Briefly, independent variables with a p-value < 0.20 in the univariate linear regression analysis were fitted in a multivariable model. Variables with a p-value > 0.05 were removed, and the potential confounding effect of each variable was assessed. The linear assumptions of continuous variables and potential interaction effects were assessed. The Hosmer–Lemeshow test was used to determine the model goodness-of-fit.
The data received from the APHP indicated that there were 433,445 pregnancies in Alberta between 2000 and 2009. Records where diabetes data were missing (n = 6,387) were not included in the analyses. Of the 427,058 pregnancy records that were examined, 28,306 (6.6%) were from First Nations women. Results for the number of pregnancies where diabetes data were available by year, age group, and ethnicity are presented in Additional file 2. The majority (52.3%) of First Nations pregnancies were among women < 25 years of age. Only 22.5% of non-First Nations women were from this age group.
The results for ethnicity comparisons for selected maternal characteristics, antenatal risk factors, and pregnancy outcomes are presented in Table 1. Between-group comparisons (First Nations vs. non-First Nations) were made among women with and without diabetes during pregnancy. For the majority of the comparisons, First Nations women tended to have more risk factors and poorer outcomes than non-First Nations women. This result suggests that, overall, First Nations women have higher-risk pregnancies. This is indicated most clearly by the elevated prevalence of a composite antepartum risk score of ≥ 7 among First Nations women compared with non-First Nations women. However, First Nations women had less pregnancy-induced hypertension, and fewer labor inductions, NICU admissions, and cesarean sections. Most of these differences by ethnicity persisted when only pregnancies affected by diabetes were compared.
The results for the within-group comparisons among First Nations women (women without diabetes in pregnancy vs. women with diabetes in pregnancy; women with GDM vs. women with pre-existing diabetes) are presented in Table 2. Compared with women without diabetes, women with diabetes tended to have more pregnancy-related risk factors, including higher composite antepartum risk scores and poorer outcomes. Compared with women with GDM, women with pre-existing diabetes were significantly more likely to have pre-existing risk factors (weight ≥ 91 kg, hypertension), higher composite antepartum risk scores, and adverse infant outcomes (preterm neonate, stillbirth, congenital anomaly, and cesarean section).
The overall crude and age-adjusted GDM prevalence values were significantly elevated for First Nations women compared with non-First Nations women. The First Nations to non-First Nations rate ratio was higher after age-adjustment (Table 3). Similarly, First Nations women had a higher prevalence of crude and age-adjusted pre-existing diabetes than non-First Nations women for all of the years included in the analysis (Table 3). Age-adjustment also resulted in a greater rate ratio between ethnicities for this comparison.
During 2000 to 2009, age-adjusted GDM prevalence increased significantly only among non-First Nations women (Figure 1; p = 0.02 for the between-ethnicity difference in AAPC). The AAPC for GDM was 1.51 [95% confidence interval (CI): -2.04–5.20; p = 0.20] among First Nations women and 4.48 (95% CI: 2.88–6.11; p = 0.01) among non-First Nations women. Prevalence of pre-existing diabetes did not increase over time among either First Nations or non-First Nations women, and there were no between-group differences (Figure 1; p = 0.95 for the difference in AAPC between ethnicities). The AAPCs for pre-existing diabetes were 1.55 (95% CI: -6.68–8.19; p = 0.32) among First Nations women and 1.35 (95% CI: -0.38–3.12; p = 0.18) among non-First Nations women.
Figure 2 presents the results for prevalence of age-specific diabetes in pregnancy by ethnicity over the entire time period. GDM prevalence was lowest for both groups among women aged 15–19 years and increased with increasing age. Pre-existing diabetes prevalence values were considerably higher among First Nations women aged 30–34 years and 35–39 years, which is consistent with the presence of early onset type 2 diabetes in these women.
The results for the final adjusted logistic regression models and estimated odds ratios (ORs) are presented in Table 4. Among all women, the factors significantly associated with an increased risk of GDM included First Nations ethnicity, age ≥ 35 years, weight ≥ 91 kg, pre-existing hypertension, previous stillbirth, previous cesarean section, and proteinuria. Age ≤ 17 years, rural residence, smoking, and drug dependence were associated with a lower risk of GDM. Among First Nations women, there were significant associations with increased GDM risk for age ≥ 35 years, weight ≥ 91 kg, previous stillbirth, previous cesarean section, previous birthing of an infant that was large for gestational age (LGA), and proteinuria. Women ≤ 17 years and with drug dependence had a lower risk of GDM.
Among all women, factors significantly associated with an increased risk of pre-existing diabetes included First Nations ethnicity, age ≥ 35 years, weight ≥ 91 kg, pre-existing hypertension, previous stillbirth, previous abortion, previous cesarean section, previous LGA infant, and proteinuria. Age ≤ 17 years, having a previous small for gestational age infant and alcohol consumption during pregnancy were associated with a lower risk of pre-existing diabetes. Among First Nations women, there were significant associations with increased pre-existing diabetes risk for the variables age ≥ 35 years, weight ≥ 91 kg, previous stillbirth, previous abortion, previous cesarean section, previous LGA infant, and proteinuria. Being at an age ≤ 17 years conferred a lower risk of pre-existing diabetes.
Our large sample size over a 10-year period allowed for analyses that indicated that having diabetes in pregnancy (particularly pre-existing diabetes) compounds already increased risks of adverse pregnancy outcomes for First Nations women. The results of our study are unique in that they are the first results that describe large-scale trends over time for both pre-existing diabetes and GDM in a First Nations population. Although GDM prevalence was disproportionately higher among First Nations women, we found that prevalence is growing more rapidly among non-First Nations women. First Nations women also suffer a greater than 2-fold higher prevalence of pre-existing diabetes, which is likely contributed to by early onset of type 2 diabetes in the prime child-bearing years (i.e., twenties and thirties) . However, the prevalence of pre-existing diabetes in pregnancy was generally stable over time amongst both groups. An additional novel finding was that the epidemiological profile of diabetes in pregnancy in Alberta does not appear to be as severe in comparison with other provinces. Our study also provides new information about previously unexplored maternal characteristics and antenatal risk factors, and their associations with diabetes in pregnancy.
This study is the first to calculate age-adjusted GDM and pre-existing diabetes prevalence among a First Nations population. Because advancing maternal age is a risk factor for GDM, and the First Nations population consists mostly of younger age groups [3, 18], the results presented in previous reports may underestimate the differences between First Nations and general populations. Being of First Nations descent was independently associated with both GDM and pre-existing diabetes in pregnancy. Finally, in addition to risk factors identified in previous studies [19–21], the results of this study indicate that previous stillbirth, previous cesarean section, previous abortion (spontaneous or therapeutic), previous LGA infant, and the presence of proteinuria are also independently associated with GDM and pre-existing diabetes in pregnancy in Indigenous women.
Values for several components of the total antepartum risk score are higher in other First Nations populations. These components include previous preterm birth , smoking during pregnancy , fetal exposure to illicit drugs , and stillbirth . In the current study, pregnancy risk factors that showed the highest disparity between First Nations and non-First Nations women included smoking anytime during pregnancy (3.2-fold), the presence of anemia (3.8-fold), alcohol consumption any time during pregnancy (6.1-fold), and drug dependency (7.3-fold). It is likely that these factors contribute to the observed poorer outcomes among First Nations infants, and interventions are clearly required to mitigate these risks. The ethnic inequalities persisted in women who only had diabetes in pregnancy. To our knowledge, this was the first study to find adverse effects by First Nations status among women with diabetes, associated with high pre-existing weight, pre-existing hypertension, proteinuria, anemia, stillbirth, smoking, alcohol consumption, and drug dependency. All of these factors were significantly more common among First Nations women. This study is also the first to compare risk factors and pregnancy outcomes by diabetes status among First Nations women only. Having diabetes (especially pre-existing) clearly increased the risk of several adverse pregnancy risk factors and outcomes, similar to previously reported results for non-Indigenous women .
This study confirmed the results of previous studies that found a higher prevalence of GDM among First Nations women [9, 19, 20, 27]. However, the epidemiological profile in Alberta did not seem to be as severe as in other provinces. The crude First Nations GDM prevalence in Alberta (4.3%) was lower compared with First Nations populations in other parts of Canada, such as Manitoba (6.9%), Quebec (8.5%), and northwestern Ontario (8.4%) [20, 21, 27]. The First Nations to non-First Nations crude rate ratio of 1.1 for GDM prevalence was also lower in Alberta compared with the 1.8 and 2.9 ratios reported for women in the provinces of Saskatchewan and Manitoba, respectively [19, 20]. Similarly, we have recently found that rate ratios for overall diabetes incidence and prevalence are also lower in Alberta compared with other provinces . The results of our study cannot explain provincial differences, but we speculate they may be related to socio-economic differences, and/or a combination of provincial and community-based programming targeting awareness such as the provincial Alberta Diabetes Strategy, the federally funded Aboriginal Diabetes Initiative, or changes in clinical practice. Future studies are needed to uncover reasons for regional variations, and should include age-adjustments for more informative comparisons across ethnic groups.
GDM prevalence is increasing in many populations worldwide , and this pattern is also present among non-First Nations Albertan women. The increasing age of pregnant non-First Nations women and an influx of minority immigrants likely have contributed to this increase in prevalence [20, 29]. The situation does not seem as clear among Indigenous populations, because prevalence is not increasing significantly in Alberta First Nations women. This is consistent with our article on overall diabetes prevalence in Alberta , which reported that overall diabetes prevalence is increasing more rapidly among the non-First Nations population. One US study found that GDM prevalence among American Indian women increased from 3.1% to 4.1% during 1989–2000 . However, studies among Aborigines in Australia have found that prevalence values are stable or even decreasing over time [31, 32].
Liu et al  reported a higher pre-existing diabetes prevalence in Ontario First Nations women (3.9%) compared with their non-First Nations counterparts (1.8%). This result is consistent with our results and with the increased numbers of young women of child-bearing age with type 2 diabetes that we and others have documented in First Nations populations [6, 7]. As with GDM, pre-existing diabetes prevalence is lower among Alberta First Nations (1.0% crude) compared with Ontario First Nations women.
To our knowledge, this study is the first to describe trends in pre-existing diabetes in pregnancy over time in an Indigenous population. The stability of prevalence in the First Nations and non-First Nations populations is surprising and encouraging, because the prevalence of pre-existing diabetes in pregnancy is increasing worldwide  and overall diabetes prevalence appears to be increasing in both the First Nations and non-First Nations populations .
There were several limitations of this study. The results cannot be generalized to non-registered First Nations individuals or to Métis individuals. These individuals could not be identified and were included in the non-First Nations population group. Also, the completeness of coverage of the First Nations identification could not be determined, so the observed ethnic (First Nations vs. non-First Nations) disparities could have been underestimated. Screening for diabetes in early pregnancy is often not performed (personal observation, E.L.T.) even though it is recommended for women with multiple risk factors . Therefore, it is also likely that some First Nations women with pre-existing diabetes were not diagnosed, and were later classified as having GDM. This error would underestimate the magnitude of the findings of worse outcomes with pre-existing diabetes than with GDM. Whether the recorded pre-existing diabetes cases were type 1 or type 2 diabetes could not be discerned from the administrative data. Clinical experience suggests that most diabetes in young First Nations women is type 2 diabetes, but the prevalence of type 2 diabetes amongst non-First Nations populations (as we defined them) is also increasing. We believe that this change is due to obesity, immigration, and the inclusion of non-registered Indigenous persons. Further research is needed to determine the specific contributions of type 1 and type 2 diabetes, but glucose control is equally important to perinatal outcomes regardless the type of pre-existing diabetes. The degree to which diabetes was successfully managed (glucose control, hemoglobin A1c) also could not be determined for the study population. Finally, the contribution of other potential contextual predictors (e.g., healthcare access, lifestyle, overweight/obesity, social environment, income) to the logistic regression models could not be assessed.
First Nations women suffer a higher prevalence of diabetes in pregnancy and more adverse pregnancy outcomes, but the prevalence in Alberta does not appear to be as high as it is in other provinces. Future studies are needed to uncover reasons for regional variations and should use age-adjustment for more informative comparisons across ethnic groups. Future and ongoing monitoring of diabetes prevalence in pregnancy, information on pregnancy outcomes, and epidemiological data on diabetes in pregnancy among other Indigenous populations (Métis, Inuit, non-registered Indigenous women) will be necessary. More complex and inclusive studies should be used to assess the contribution of other potential contextual predictors (e.g., healthcare access, lifestyle, social environment, income, medical management). Our findings should allow government and healthcare organizations to develop policy and plan healthcare delivery, and to evaluate efforts and assess their cost-effectiveness, so that perinatal care in this population can be improved.
Average annual percent change
Alberta perinatal health program
Gestational diabetes mellitus
Large for gestational age
Neonatal intensive care unit
Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002, 25 (10): 1862-1868. 10.2337/diacare.25.10.1862.
Philipps LH, Santhakumaran S, Gale C, Prior E, Logan KM, Hyde MJ, Modi N: The diabetic pregnancy and offspring BMI in childhood: a systematic review and meta-analysis. Diabetologia. 2011, 54 (8): 1957-1966. 10.1007/s00125-011-2180-y.
Damm P: Future risk of diabetes in mother and child after gestational diabetes mellitus. Int J Gynaecol Obstet. 2009, 104 (Suppl 1): S25-S26.
Osgood ND, Dyck RF, Grassmann WK: The inter- and intragenerational impact of gestational diabetes on the epidemic of type 2 diabetes. Am J Public Health. 2011, 101 (1): 173-179. 10.2105/AJPH.2009.186890.
Young TK, Reading J, Elias B, O’Neil JD: Type 2 diabetes mellitus in Canada’s first nations: status of an epidemic in progress. CMAJ. 2000, 163 (5): 561-566.
Dyck R, Osgood N, Lin TH, Gao A, Stang MR: Epidemiology of diabetes mellitus among first nations and non-first nations adults. CMAJ. 2010, 182 (3): 249-256. 10.1503/cmaj.090846.
Oster RT, Johnson JA, Hemmelgarn BR, King M, Balko SU, Svenson LW, Crowshoe L, Toth EL: Recent epidemiologic trends of diabetes mellitus among status aboriginal adults. CMAJ. 2011, 183 (12): E803-E808. 10.1503/cmaj.101882.
Willows ND, Sanou D, Bell RC: Assessment of Canadian cree infants’ birth size using the WHO child growth standards. Am J Hum Biol. 2011, 23 (1): 126-131. 10.1002/ajhb.21115.
Mohamed N, Dooley J: Gestational diabetes and subsequent development of NIDDM in aboriginal women of northwestern Ontario. Int J Circumpolar Health. 1998, 57 (Suppl 1): 355-358.
Young TK, Martens PJ, Taback SP, Sellers EA, Dean HJ, Cheang M, Flett B: Type 2 diabetes mellitus in children: prenatal and early infancy risk factors among native Canadians. Arch Pediatr Adolesc Med. 2002, 156 (7): 651-655. 10.1001/archpedi.156.7.651.
Dyck RF, Tan L, Hoeppner VH: Short report: body mass index, gestational diabetes and diabetes mellitus in three northern Saskatchewan aboriginal communities. Chronic Dis Can. 1995, 16 (1): 24-26.
Reproductive Health Working Group: Alberta reproductive health: pregnancies and births 2009. http://www.health.alberta.ca/documents/Reproductive-Health-2009.pdf,
Canadian Diabetes Association: Canadian diabetes association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008, 32 (Suppl 1): S1-S201.
Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva AD, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y, Schmidt MI, International Association of Diabetes and Pregnancy Study Groups Consensus Panel: International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010, 33 (3): 676-682.
Burstyn I: Antepartum risk score predicts adverse birth outcomes. J Obstet Gynaecol Can. 2010, 32 (1): 16-20.
Statistics Canada: National households survey, 2011: aboriginal peoples in Canada: first nations people, Métis, and Inuit. http://www12.statcan.gc.ca/nhs-enm/2011/as-sa/99-011-x/99-011-x2011001-eng.pdf,
Statistics Canada: Pregnancy outcomes by age group: 2005. http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/hlth65a-eng.htm,
Statistics Canada: Aboriginal peoples in Canada in 2006: 2006 census. 2006, Statistics Canada: Ottawa, ON
Dyck R, Klomp H, Tan LK, Turnell RW, Boctor MA: A comparison of rates, risk factors, and outcomes of gestational diabetes between aboriginal and non-aboriginal women in the Saskatoon health district. Diabetes Care. 2002, 25 (3): 487-493. 10.2337/diacare.25.3.487.
Aljohani N, Rempel BM, Ludwig S, Morris M, McQuillen K, Cheang M, Murray R, Shen GX: Gestational diabetes in Manitoba during a twenty-year period. Clin Invest Med. 2008, 31 (3): E131-E137.
Harris SB, Caulfield LE, Sugamori ME, Whalen EA, Henning B: The epidemiology of diabetes in pregnant native Canadians. A risk profile. Diabetes Care. 1997, 20 (9): 1422-1425. 10.2337/diacare.20.9.1422.
Auger N, Fon Sing M, Park AL, Lo E, Trempe N, Luo ZC: Preterm birth in the inuit and first nations populations of Québec, Canada, 1981-2008. Int J Circumpolar Health. 2012, 71: 17520-
Wenman WM, Joffres MR, Tataryn IV: Edmonton perinatal infections group: a prospective cohort study of pregnancy risk factors and birth outcomes in aboriginal women. CMAJ. 2004, 171 (6): 585-589. 10.1503/cmaj.1031730.
Kelly L, Dooley J, Cromarty H, Minty B, Morgan A, Madden S, Hopman W: Narcotic-exposed neonates in a first nations population in northwestern Ontario: incidence and implications. Can Fam Physician. 2011, 57 (11): e441-e447.
Simonet F, Wilkins R, Luo ZC: Temporal trends in inuit, first nations and non-aboriginal birth outcomes in rural and northern Quebec. Int J Circumpolar Health. 2012, 71: A risk profile-doi:10.3402/ijch.v 71i0.18791
Temple R, Murphy H: Type 2 diabetes in pregnancy: an increasing problem. Best Pract Res Clin Endocrinol Metab. 2010, 24 (4): 591-603. 10.1016/j.beem.2010.05.011.
Godwin M, Muirhead M, Huynh J, Helt B, Grimmer J: Prevalence of gestational diabetes mellitus among swampy cree women in moose factory. James Bay CMAJ. 1999, 160 (9): 1299-1302.
Hunt KJ, Schuller KL: The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am. 2007, 34 (2): 173-199. 10.1016/j.ogc.2007.03.002.
Urquia M, Glazier RH, Berger H, Ying I, De Souza L, Ray JG: Gestational diabetes among immigrant women. Epidemiology. 2011, 22 (6): 879-880. 10.1097/EDE.0b013e31823199ee.
Moum KR, Holzman GS, Harwell TS, Parsons SL, Adams SD, Oser CS, Spence MR, Helgerson SD, Gohdes D: Increasing rate of diabetes in pregnancy among American Indian and white mothers in Montana and North Dakota, 1989-2000. Matern Child Health J. 2004, 8: 71-76.
Ishak M, Petocz P: Gestational diabetes among aboriginal Australians: prevalence, time trend, and comparisons with non-aboriginal Australians. Ethn Dis. 2003, 13: 55-60.
Kim S, Humphrey MD: Decrease in incidence of gestational diabetes mellitus in Far North Queensland between 1992 and 1996. Aust N Z J Obstet Gynaecol. 1999, 39: 40-43. 10.1111/j.1479-828X.1999.tb03441.x.
Liu SL, Shah BR, Naqshbandi M, Tran V, Harris SB: Increased rates of adverse outcomes for gestational diabetes and pre-pregnancy diabetes in on-reserve First Nations women in Ontario. Canada Diabet Med. 2012, 29 (8): e180-e183. 10.1111/j.1464-5491.2012.03691.x.
Feig DS, Palda VA: Type 2 diabetes in pregnancy: a growing concern. Lancet. 2002, 359 (9318): 1690-1692. 10.1016/S0140-6736(02)08599-9.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2393/14/136/prepub
This study was based in part on data provided by the Alberta Perinatal Health Program and Alberta Health. The interpretations and conclusions contained herein are those of the authors, and do not necessarily represent those of the Alberta Perinatal Health Program, Alberta Health, or the Government of Alberta. Neither the Alberta Perinatal Health Program, Alberta Health, nor the Government of Alberta expressed any opinions about this study.
This study was funded in part by the Canadian Institutes for Health Research, Institute of Aboriginal Peoples Health.
The authors declare that they have no competing interests.
RTO contributed to the study design, obtained the data, conducted statistical analyses, and wrote the manuscript. MK, DWM, and MJM contributed to the study design and the discussion, and reviewed and edited the manuscript. ELT was the principal investigator, contributed to the study design and the discussion, and reviewed and edited the manuscript. All authors read and approved the final manuscript.